Fuse Medical, Inc. (FZMD)
USD 0.09
(-9.91%)
USD 0.09
(-9.91%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 10.35 Million USD | -16.24% |
| 2022 | 12.35 Million USD | -12.56% |
| 2021 | 14.13 Million USD | 2.91% |
| 2020 | 13.73 Million USD | -5.65% |
| 2019 | 14.55 Million USD | -2.63% |
| 2018 | 14.94 Million USD | 35.74% |
| 2017 | 11.01 Million USD | 1189.4% |
| 2016 | 854.05 Thousand USD | -52.67% |
| 2015 | 1.8 Million USD | 22.76% |
| 2014 | 1.46 Million USD | 1244.99% |
| 2013 | 109.28 Thousand USD | 7.55% |
| 2012 | 101.61 Thousand USD | -17.49% |
| 2011 | 123.15 Thousand USD | -26.37% |
| 2010 | 167.26 Thousand USD | 38.01% |
| 2009 | 121.19 Thousand USD | -12.86% |
| 2008 | 139.08 Thousand USD | -9.44% |
| 2007 | 153.59 Thousand USD | -15.9% |
| 2006 | 182.62 Thousand USD | 17.03% |
| 2005 | 156.05 Thousand USD | -59.49% |
| 2004 | 385.25 Thousand USD | 129.2% |
| 2003 | 168.08 Thousand USD | -14.12% |
| 2002 | 195.72 Thousand USD | -45.12% |
| 2001 | 356.61 Thousand USD | -44.88% |
| 2000 | 647 Thousand USD | 223.5% |
| 1999 | 200 Thousand USD | 150.0% |
| 1998 | 80 Thousand USD | 33.33% |
| 1997 | 60 Thousand USD | -25.0% |
| 1996 | 80 Thousand USD | -11.11% |
| 1995 | 90 Thousand USD | 12.5% |
| 1994 | 80 Thousand USD | -66.67% |
| 1993 | 240 Thousand USD | -86.21% |
| 1992 | 1.74 Million USD | -56.17% |
| 1991 | 3.97 Million USD | 15.74% |
| 1990 | 3.42 Million USD | -2.0% |
| 1989 | 3.5 Million USD | -14.84% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q2 | 3.1 Million USD | 3.97% |
| 2023 FY | 10.35 Million USD | -16.24% |
| 2023 Q1 | 2.98 Million USD | -3.85% |
| 2022 Q1 | 3.24 Million USD | -22.13% |
| 2022 FY | 12.35 Million USD | -12.56% |
| 2022 Q4 | 3.1 Million USD | 3.02% |
| 2022 Q3 | 3.01 Million USD | 0.46% |
| 2022 Q2 | 2.99 Million USD | -7.8% |
| 2021 Q1 | 3.01 Million USD | -16.88% |
| 2021 Q2 | 3.87 Million USD | 28.33% |
| 2021 Q4 | 4.17 Million USD | 35.93% |
| 2021 FY | 14.13 Million USD | 2.91% |
| 2021 Q3 | 3.06 Million USD | -20.7% |
| 2020 Q2 | 2.61 Million USD | -33.05% |
| 2020 Q4 | 3.62 Million USD | 1.15% |
| 2020 FY | 13.73 Million USD | -5.65% |
| 2020 Q1 | 3.9 Million USD | -5.34% |
| 2020 Q3 | 3.58 Million USD | 37.35% |
| 2019 FY | 14.55 Million USD | -2.63% |
| 2019 Q1 | 3.39 Million USD | -13.05% |
| 2019 Q2 | 3 Million USD | -11.45% |
| 2019 Q3 | 4.03 Million USD | 34.09% |
| 2019 Q4 | 4.12 Million USD | 2.25% |
| 2018 FY | 14.94 Million USD | 35.74% |
| 2018 Q2 | 3.91 Million USD | 3.27% |
| 2018 Q3 | 3.34 Million USD | -14.54% |
| 2018 Q4 | 3.9 Million USD | 16.82% |
| 2018 Q1 | 3.78 Million USD | -63.3% |
| 2017 Q4 | 10.32 Million USD | 4651.02% |
| 2017 Q2 | 220.28 Thousand USD | -12.79% |
| 2017 Q3 | 217.25 Thousand USD | -1.37% |
| 2017 Q1 | 252.59 Thousand USD | -0.25% |
| 2017 FY | 11.01 Million USD | 1189.4% |
| 2016 FY | 854.05 Thousand USD | -52.67% |
| 2016 Q4 | 253.23 Thousand USD | 39.04% |
| 2016 Q3 | 182.13 Thousand USD | -2.32% |
| 2016 Q1 | 232.21 Thousand USD | -2.98% |
| 2016 Q2 | 186.46 Thousand USD | -19.71% |
| 2015 Q4 | 239.35 Thousand USD | -68.31% |
| 2015 FY | 1.8 Million USD | 22.76% |
| 2015 Q1 | 384.67 Thousand USD | -3.57% |
| 2015 Q2 | 424.97 Thousand USD | 10.48% |
| 2015 Q3 | 755.36 Thousand USD | 77.75% |
| 2014 FY | 1.46 Million USD | 1244.99% |
| 2014 Q1 | 218.93 Thousand USD | 355.26% |
| 2014 Q3 | 529.48 Thousand USD | 44.74% |
| 2014 Q4 | 398.92 Thousand USD | -24.66% |
| 2014 Q2 | 365.81 Thousand USD | 67.09% |
| 2013 FY | 109.28 Thousand USD | 7.55% |
| 2013 Q2 | 22.18 Thousand USD | -8.99% |
| 2013 Q3 | 30.55 Thousand USD | 37.76% |
| 2013 Q4 | 48.08 Thousand USD | 57.37% |
| 2013 Q1 | 24.37 Thousand USD | -24.24% |
| 2012 Q3 | 26.39 Thousand USD | 10.56% |
| 2012 FY | 101.61 Thousand USD | -17.49% |
| 2012 Q4 | 32.17 Thousand USD | 21.91% |
| 2012 Q2 | 23.87 Thousand USD | 7.45% |
| 2012 Q1 | 22.21 Thousand USD | -23.76% |
| 2011 Q3 | 20.73 Thousand USD | 17.09% |
| 2011 Q4 | 29.13 Thousand USD | 40.51% |
| 2011 Q1 | 24.94 Thousand USD | -58.27% |
| 2011 FY | 123.15 Thousand USD | -26.37% |
| 2011 Q2 | 17.71 Thousand USD | -28.99% |
| 2010 Q4 | 59.77 Thousand USD | -25.96% |
| 2010 Q2 | 24.32 Thousand USD | -7.03% |
| 2010 Q1 | 26.16 Thousand USD | -27.43% |
| 2010 Q3 | 80.72 Thousand USD | 231.88% |
| 2010 FY | 167.26 Thousand USD | 38.01% |
| 2009 Q4 | 36.05 Thousand USD | 44.51% |
| 2009 Q3 | 24.94 Thousand USD | -3.52% |
| 2009 Q2 | 25.85 Thousand USD | -16.33% |
| 2009 Q1 | 30.9 Thousand USD | -21.74% |
| 2009 FY | 121.19 Thousand USD | -12.86% |
| 2008 Q1 | 36.59 Thousand USD | -4.96% |
| 2008 Q3 | 35.65 Thousand USD | 25.85% |
| 2008 FY | 139.08 Thousand USD | -9.44% |
| 2008 Q4 | 39.48 Thousand USD | 10.75% |
| 2008 Q2 | 28.33 Thousand USD | -22.59% |
| 2007 FY | 153.59 Thousand USD | -15.9% |
| 2007 Q2 | 30.4 Thousand USD | -9.26% |
| 2007 Q3 | 49.01 Thousand USD | 61.21% |
| 2007 Q1 | 33.5 Thousand USD | -17.61% |
| 2007 Q4 | 38.5 Thousand USD | -21.44% |
| 2006 Q2 | 36.52 Thousand USD | 6.25% |
| 2006 FY | 182.62 Thousand USD | 17.03% |
| 2006 Q4 | 40.66 Thousand USD | -39.58% |
| 2006 Q1 | 34.37 Thousand USD | -22.59% |
| 2006 Q3 | 67.3 Thousand USD | 84.27% |
| 2005 FY | 156.05 Thousand USD | -59.49% |
| 2005 Q3 | 30.02 Thousand USD | -9.16% |
| 2005 Q2 | 33.04 Thousand USD | -41.42% |
| 2005 Q1 | 56.41 Thousand USD | 54.26% |
| 2005 Q4 | 44.41 Thousand USD | 47.94% |
| 2004 FY | 385.25 Thousand USD | 129.2% |
| 2004 Q3 | 266.78 Thousand USD | 694.84% |
| 2004 Q4 | 36.56 Thousand USD | -86.29% |
| 2004 Q2 | 33.56 Thousand USD | -8.58% |
| 2004 Q1 | 36.71 Thousand USD | -23.82% |
| 2003 Q4 | 48.19 Thousand USD | 57.4% |
| 2003 Q1 | 41.83 Thousand USD | -13.82% |
| 2003 Q2 | 47.08 Thousand USD | 12.54% |
| 2003 Q3 | 30.61 Thousand USD | -34.97% |
| 2003 FY | 168.08 Thousand USD | -14.12% |
| 2002 Q2 | 68.64 Thousand USD | 38.5% |
| 2002 Q1 | 49.56 Thousand USD | -8.57% |
| 2002 Q3 | 23.3 Thousand USD | -66.05% |
| 2002 Q4 | 48.54 Thousand USD | 108.3% |
| 2002 FY | 195.72 Thousand USD | -45.12% |
| 2001 FY | 356.61 Thousand USD | -44.88% |
| 2001 Q4 | 54.2 Thousand USD | -29.72% |
| 2001 Q3 | 77.13 Thousand USD | 5.97% |
| 2001 Q2 | 72.79 Thousand USD | -25.31% |
| 2001 Q1 | 97.46 Thousand USD | -10.76% |
| 2000 Q3 | 110 Thousand USD | -45.0% |
| 2000 Q4 | 109.22 Thousand USD | -0.71% |
| 2000 FY | 647 Thousand USD | 223.5% |
| 2000 Q1 | 170 Thousand USD | -5.56% |
| 2000 Q2 | 200 Thousand USD | 17.65% |
| 1999 Q1 | 20 Thousand USD | 0.0% |
| 1999 Q2 | 50 Thousand USD | 150.0% |
| 1999 FY | 200 Thousand USD | 150.0% |
| 1999 Q3 | 120 Thousand USD | 140.0% |
| 1999 Q4 | 180 Thousand USD | 50.0% |
| 1998 Q3 | 20 Thousand USD | 0.0% |
| 1998 FY | 80 Thousand USD | 33.33% |
| 1998 Q1 | 20 Thousand USD | 0.0% |
| 1998 Q2 | 20 Thousand USD | 0.0% |
| 1998 Q4 | 20 Thousand USD | 0.0% |
| 1997 FY | 60 Thousand USD | -25.0% |
| 1997 Q4 | 20 Thousand USD | 100.0% |
| 1997 Q3 | 10 Thousand USD | -50.0% |
| 1997 Q2 | 20 Thousand USD | 100.0% |
| 1997 Q1 | 10 Thousand USD | -50.0% |
| 1996 Q2 | 20 Thousand USD | 0.0% |
| 1996 FY | 80 Thousand USD | -11.11% |
| 1996 Q1 | 20 Thousand USD | 0.0% |
| 1996 Q4 | 20 Thousand USD | 0.0% |
| 1996 Q3 | 20 Thousand USD | 0.0% |
| 1995 Q1 | 20 Thousand USD | 0.0% |
| 1995 Q2 | 20 Thousand USD | 0.0% |
| 1995 Q4 | 20 Thousand USD | -33.33% |
| 1995 FY | 90 Thousand USD | 12.5% |
| 1995 Q3 | 30 Thousand USD | 50.0% |
| 1994 Q3 | 10 Thousand USD | 0.0% |
| 1994 Q4 | 20 Thousand USD | 100.0% |
| 1994 FY | 80 Thousand USD | -66.67% |
| 1993 Q1 | 60 Thousand USD | 200.0% |
| 1993 Q2 | -20 Thousand USD | -133.33% |
| 1993 FY | 240 Thousand USD | -86.21% |
| 1993 Q3 | 180 Thousand USD | 1000.0% |
| 1992 Q1 | 470 Thousand USD | -29.85% |
| 1992 FY | 1.74 Million USD | -56.17% |
| 1992 Q4 | 20 Thousand USD | -87.5% |
| 1992 Q3 | 160 Thousand USD | -63.64% |
| 1992 Q2 | 439.99 Thousand USD | -6.38% |
| 1991 Q1 | 869.99 Thousand USD | 3.57% |
| 1991 FY | 3.97 Million USD | 15.74% |
| 1991 Q4 | 670 Thousand USD | -55.33% |
| 1991 Q3 | 1.49 Million USD | 100.0% |
| 1991 Q2 | 750 Thousand USD | -13.79% |
| 1990 FY | 3.42 Million USD | -2.0% |
| 1990 Q2 | 830 Thousand USD | 1.22% |
| 1990 Q1 | 820 Thousand USD | 9.33% |
| 1990 Q3 | 1.02 Million USD | 24.1% |
| 1990 Q4 | 840 Thousand USD | -18.45% |
| 1989 Q3 | 799.99 Thousand USD | -4.76% |
| 1989 FY | 3.5 Million USD | -14.84% |
| 1989 Q2 | 840 Thousand USD | 0.0% |
| 1989 Q4 | 750 Thousand USD | -6.25% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 740.67 Thousand USD | -1297.374% |
| IR-Med Inc. | 4.89 Million USD | -111.484% |
| Polarean Imaging plc | 12.24 Million USD | 15.458% |
| Medical Supply International USA, Inc. | 1.32 Million USD | -683.798% |
| Avitar, Inc. | 3.56 Million USD | -189.956% |
| AVITA Medical, Inc. | 80.77 Million USD | 87.187% |
| Manhattan Scientifics, Inc. | 703 Thousand USD | -1372.264% |
| Össur hf. | 396.18 Million USD | 97.388% |
| Zecotek Photonics Inc. | 3.46 Million USD | -199.008% |
| QHSLab, Inc. | 961.65 Thousand USD | -976.273% |
| Wellstar International, Inc. | 1.79 Million USD | -476.7% |
| Össur hf. | 396.18 Million USD | 97.388% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 21.77 Million USD | 52.475% |
| Escalon Medical Corp. | 5.25 Million USD | -97.118% |
| Aurora Spine Corporation | 8.65 Million USD | -19.55% |
| BrainsWay Ltd. | 28.01 Million USD | 63.059% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 9.56 Million USD | -8.215% |
| Hamilton Thorne Ltd. | 33.57 Million USD | 69.171% |
| Vivos Inc. | 2.78 Million USD | -271.353% |
| MicroPort Scientific Corporation | 1.04 Billion USD | 99.013% |
| Kelyniam Global, Inc. | 2.27 Million USD | -354.897% |
| REMSleep Holdings, Inc. | 1.01 Million USD | -919.803% |
| CYduct Diagnostics, Inc. | 435.5 Thousand USD | -2276.582% |
| Nanomix Corporation | 8.36 Million USD | -23.69% |
| Theraclion SA | 7.43 Million USD | -39.116% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 1.29 Million USD | -699.489% |
| Positron Corporation | 1 Million USD | -927.516% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.11 Million USD | -232.75% |
| Lombard Medical, Inc. | 30.29 Million USD | 65.83% |
| ALR Technologies Inc. | 6.33 Million USD | -63.353% |
| Stratec SE | 46.32 Million USD | 77.656% |
| Vycor Medical, Inc. | 1.27 Million USD | -711.471% |
| Heart Tronics, Inc. | 14.46 Million USD | 28.424% |
| Nu-Med Plus, Inc. | 120.52 Thousand USD | -8487.371% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -4914.081% |
| SANUWAVE Health, Inc. | 14.15 Million USD | 26.86% |
| VMS Rehab Systems, Inc. | 63.63 USD | -16265835.879% |
| Guided Therapeutics, Inc. | 3.49 Million USD | -196.307% |
| Ingen Technologies, Inc. | 1.88 Million USD | -449.883% |
| Odyssey Group International, Inc. | -14.26 Million USD | 172.575% |
| United American Healthcare Corporation | 59 Thousand USD | -17442.398% |
| ECGI Holdings, Inc. | 407.48 Thousand USD | -2439.974% |
| Capital Group Holdings, Inc. | 634.68 Thousand USD | -1530.725% |
| ADM Tronics Unlimited, Inc. | 1.69 Million USD | -510.417% |
| Urologix, Inc. | 10.09 Million USD | -2.557% |
| Rapid Therapeutic Science Laboratories, Inc. | 1.26 Million USD | -719.263% |
| Nexeon MedSystems Inc. | 5.94 Million USD | -73.999% |
| SS Innovations International, Inc. | 21.38 Million USD | 51.594% |
| Qualis Innovations, Inc. | 230.24 Thousand USD | -4395.296% |
| Smith & Nephew plc | 3.46 Billion USD | 99.701% |
| NIOX Group Plc | 22.27 Million USD | 53.541% |
| Broncus Holding Corporation | 38.15 Million USD | 72.871% |
| Brain Scientific Inc. | 9.66 Million USD | -7.113% |
| Pressure BioSciences, Inc. | 10.3 Million USD | -0.457% |
| Health Logic Interactive Inc. | 60.69 Thousand USD | -16951.657% |